Your Supply Chain On Inflation: An Outsourcing Analysis
Outsourced Pharma Chief Editor Louis Garguilo has been an ahead-of-the-curve chronicler of inflation in the development and manufacturing supply chain. Based on interviews with biopharma professionals – from CEOs to frontline workers and consultants – he’s kept readers informed of rising outsourcing challenges, including the price for materials and services at CDMOs, and hard-to-find capacity as supply chains remain strained. Now we’ve collected four of Garguilo’s editorials with outsourcing professionals to help you understand what they and the entire industry is experiencing, what you can expect in 2022, and some steps you might be able to take to mitigate these market forces.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.